The kappa opioid receptor antagonist JDTic attenuates alcohol seeking and withdrawal anxiety

Addiction Biology

Volumn 17, Issue 3, 2012, Pages 634-647

  Schank, Jesse R ^a   Goldstein, Andrea L ^a   Rowe, Kelly E ^a   King, Courtney E ^a   Marusich, Julie A ^b   Wiley, Jenny L ^b   Carroll, F Ivy ^b   Thorsell, Annika ^a   Heilig, Markus ^a  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^b RTI INTERNATIONAL   (United States)

Author keywords

Alcoholism; dynorphin; ethanol; reinstatement; self administration; stress

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; ALCOHOL; KAPPA OPIATE RECEPTOR ANTAGONIST; KAPPA OPIATE RECEPTOR ANTAGONIST JDTIC; NORBINALTORPHIMINE; SUCROSE; UNCLASSIFIED DRUG;

ALCOHOL WITHDRAWAL; ALCOHOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; HANGOVER; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STRESS; TRANQUILIZING ACTIVITY;

ALCOHOLISM; ANIMALS; ANXIETY; CENTRAL NERVOUS SYSTEM DEPRESSANTS; CONDITIONING, OPERANT; CUES; DYNORPHINS; ETHANOL; MALE; NARCOTIC ANTAGONISTS; PIPERIDINES; RATS; RATS, WISTAR; RECEPTORS, OPIOID, KAPPA; RECURRENCE; STRESS, PSYCHOLOGICAL; SUBSTANCE WITHDRAWAL SYNDROME; TETRAHYDROISOQUINOLINES;

EID: 84860260534     PISSN: 13556215     EISSN: 13691600     Source Type: Journal    
DOI: 10.1111/j.1369-1600.2012.00455.x     Document Type: Article

References (59)

1. Aldrich JV, Patkar KA, McLaughlin JP, (2009) Zyklophin, a systemically active selective kappa opioid receptor peptide antagonist with short duration of action. Proc Natl Acad Sci U S A 106: 18396-18401.
2. Beardsley PM, Howard JL, Shelton KL, Carroll FI, (2005) Differential effects of the novel kappa opioid receptor antagonist, JDTic, on reinstatement of cocaine-seeking induced by footshock stressors vs cocaine primes and its antidepressant-like effects in rats. Psychopharmacology (Berl) 183: 118-126.
3. Bennett MA, Murray TF, Aldrich JV, (2002) Identification of arodyn, a novel acetylated dynorphin A-(1-11) analogue, as a kappa opioid receptor antagonist. J Med Chem 45: 5617-5619.
4. Blednov YA, Walker D, Martinez M, Harris RA, (2006) Reduced alcohol consumption in mice lacking preprodynorphin. Alcohol 40: 73-86.
5. Broadbear JH, Negus SS, Butelman ER, de Costa BR, Woods JH, (1994) Differential effects of systemically administered nor-binaltorphimine (nor-BNI) on kappa-opioid agonists in the mouse writhing assay. Psychopharmacology (Berl) 115: 311-319.
6. Bruchas MR, Land BB, Chavkin C, (2010) The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors. Brain Res 1314: 44-55.
7. Bruchas MR, Yang T, Schreiber S, Defino M, Kwan SC, Li S, Chavkin C, (2007) Long-acting kappa opioid antagonists disrupt receptor signaling and produce noncompetitive effects by activating c-Jun N-terminal kinase. J Biol Chem 282: 29803-29811.
8. Carroll I, Thomas JB, Dykstra LA, Granger AL, Allen RM, Howard JL, Pollard GT, Aceto MD, Harris LS, (2004) Pharmacological properties of JDTic: a novel kappa-opioid receptor antagonist. Eur J Pharmacol 501: 111-119.
9. Chen S, Zhang X, Yang D, Du Y, Li L, Li X, Ming M, Le W, (2008) D2/D3 receptor agonist ropinirole protects dopaminergic cell line against rotenone-induced apoptosis through inhibition of caspase- and JNK-dependent pathways. FEBS Lett 582: 603-610.
10. Ciccocioppo R, Martin-Fardon R, Weiss F, (2002) Effect of selective blockade of mu(1) or delta opioid receptors on reinstatement of alcohol-seeking behavior by drug-associated stimuli in rats. Neuropsychopharmacology 27: 391-399.
11. Cippitelli A, Karlsson C, Shaw JL, Thorsell A, Gehlert DR, Heilig M, (2010) Suppression of alcohol self-administration and reinstatement of alcohol seeking by melanin-concentrating hormone receptor 1 (MCH1-R) antagonism in Wistar Rats. Psychopharmacology (Berl) 211: 367-375.
12. Funada M, Suzuki T, Narita M, Misawa M, Nagase H, (1993) Blockade of morphine reward through the activation of kappa-opioid receptors in mice. Neuropharmacology 32: 1315-1323.
13. Gehlert DR, Cippitelli A, Thorsell A, Le AD, Hipskind PA, Hamdouchi C, Lu J, Hembre EJ, Cramer J, Song M, McKinzie D, Morin M, Ciccocioppo R, Heilig M, (2007) 3-(4-Chloro-2-morpholin-4-Yl-thiazol-5-Yl)-8-(1-ethylpropyl)-2,6- dimethyl- imidazo[1,2-b]pyridazine: a novel brain-penetrant, orally available corticotropin-releasing factor receptor 1 antagonist with efficacy in animal models of alcoholism. J Neurosci 27: 2718-2726.
14. Glick SD, Maisonneuve IM, Raucci J, Archer S, (1995) Kappa opioid inhibition of morphine and cocaine self-administration in rats. Brain Res 681: 147-152.
15. Heilig M, Koob GF, (2007) A key role for corticotropin-releasing factor in alcohol dependence. Trends Neurosci 30: 399-406.
16. Holter SM, Henniger MS, Lipkowski AW, Spanagel R, (2000) Kappa-opioid receptors and relapse-like drinking in long-term ethanol-experienced rats. Psychopharmacology (Berl) 153: 93-102.
17. Hurd YL, Brown EE, Finlay JM, Fibiger HC, Gerfen CR, (1992) Cocaine self-administration differentially alters MRNA expression of striatal peptides. Mol Brain Res 13: 165-170.
18. Jackson KJ, Carroll FI, Negus SS, Damaj MI, (2010) Effect of the selective kappa-opioid receptor antagonist JDTic on nicotine antinociception, reward, and withdrawal in the mouse. Psychopharmacology (Berl) 210: 285-294.
19. Knoll AT, Carlezon WA, (2010) Dynorphin, stress, and depression. Brain Res 1314: 56-73.
20. Knoll AT, Meloni EG, Thomas JB, Carroll FI, Carlezon WA, (2007) Anxiolytic-like effects of kappa-opioid receptor antagonists in models of unlearned and learned fear in rats. J Pharmacol Exp Ther 323: 838-845.
21. Kovacs KM, Szakall I, O'Brien D, Wang R, Vinod KY, Saito M, Simonin F, Kieffer BL, Vadasz C, (2005) Decreased oral self-administration of alcohol in kappa-opioid receptor knock-out mice. Alcohol Clin Exp Res 29: 730-738.
22. Kuzmin AV, Gerrits MA, Van Ree JM, (1998) Kappa-opioid receptor blockade with nor-binaltorphimine modulates cocaine self-administration in drug-naive rats. Eur J Pharmacol 358: 197-202.
23. Land BB, Bruchas MR, Lemos JC, Xu M, Melief EJ, Chavkin C, (2008) The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system. J Neurosci 28: 407-414.
24. Land BB, Bruchas MR, Schattauer S, Giardino WJ, Aita M, Messinger D, Hnasko TS, Palmiter RD, Chavkin C, (2009) Activation of the kappa opioid receptor in the dorsal raphe nucleus mediates the aversive effects of stress and reinstates drug seeking. Proc Natl Acad Sci U S A 106: 19168-19173.
25. Le AD, Poulos CX, Harding S, Watchus J, Juzytsch W, Shaham Y, (1999) Effects of naltrexone and fluoxetine on alcohol self-administration and reinstatement of alcohol seeking induced by priming injections of alcohol and exposure to stress. Neuropsychopharmacology 21: 435-444.
26. Le AD, Quan B, Juzytch W, Fletcher PJ, Joharchi N, Shaham Y, (1998) Reinstatement of alcohol-seeking by priming injections of alcohol and exposure to stress in rats. Psychopharmacology (Berl) 135: 169-174.
27. Le Merrer J, Becker JA, Befort K, Kieffer BL, (2009) Reward processing by the opioid system in the brain. Physiol Rev 89: 1379-1412.
28. Lindholm S, Ploj K, Franck J, Nylander I, (2000) Repeated ethanol administration induces short- and long-term changes in enkephalin and dynorphin tissue concentrations in rat brain. Alcohol 22: 165-171.
29. Lindholm S, Rosin A, Dahlin I, Georgieva J, Franck J, (2007) Ethanol alters the effect of kappa receptor ligands on dopamine release in the nucleus accumbens. Physiol Behav 92: 167-171.
30. Lindholm S, Werme M, Brene S, Franck J, (2001) The selective kappa-opioid receptor agonist U50,488H attenuates voluntary ethanol intake in the rat. Behav Brain Res 120: 137-146.
31. Liu X, Weiss F, (2002) Additive effect of stress and drug cues on reinstatement of ethanol seeking: exacerbation by history of dependence and role of concurrent activation of corticotropin-releasing factor and opioid mechanisms. J Neurosci 22: 7856-7861.
32. Logrip ML, Janak PH, Ron D, (2008) Dynorphin is a downstream effector of striatal bdnf regulation of ethanol intake. FASEB J 22: 2393-2404.
33. Logrip ML, Janak PH, Ron D, (2009) Blockade of ethanol reward by the kappa opioid receptor agonist U50,488H. Alcohol 43: 359-365.
34. Marchant NJ, Densmore VS, Osborne PB, (2007) Coexpression of prodynorphin and corticotrophin-releasing hormone in the rat central amygdala: evidence of two distinct endogenous opioid systems in the lateral division. J Comp Neurol 504: 702-715.
35. Marinelli PW, Funk D, Harding S, Li Z, Juzytsch W, Le AD, (2009) Roles of opioid receptor subtypes in mediating alcohol-seeking induced by discrete cues and context. Eur J Neurosci 30: 671-678.
36. Marinelli PW, Lam M, Bai L, Quirion R, Gianoulakis C, (2006) A microdialysis profile of dynorphin a release in the rat nucleus accumbens following alcohol administration. Alcohol Clin Exp Res 30: 982-990.
37. McLaughlin JP, Land BB, Li S, Pintar JE, Chavkin C, (2006) Prior activation of kappa opioid receptors by u50,488 mimics repeated forced swim stress to potentiate cocaine place preference conditioning. Neuropsychopharmacology 31: 787-794.
38. McLaughlin JP, Marton-Popovici M, Chavkin C, (2003) Kappa opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses. J Neurosci 23: 5674-5683.
39. Melief EJ, Miyatake M, Bruchas MR, Chavkin C, (2010) Ligand-directed c-Jun N-terminal kinase activation disrupts opioid receptor signaling. Proc Natl Acad Sci U S A 107: 11608-11613.
40. Melief EJ, Miyatake M, Carroll FI, Beguin C, Carlezon WA Jr, Cohen BM, Grimwood S, Mitch CH, Rorick-Kehn L, Chavkin C, (2011) Duration of action of a broad range of selective {kappa}-opioid receptor antagonists is positively correlated with c-Jun N-terminal kinase-1 activation. Mol Pharmacol 80: 920-929.
41. Mitchell JM, Liang MT, Fields HL, (2005) A single injection of the kappa opioid antagonist norbinaltorphimine increases ethanol consumption in rats. Psychopharmacology (Berl) 182: 384-392.
42. Nealey KA, Smith AW, Davis SM, Smith DG, Walker BM, (2011) Kappa-opioid receptors are implicated in the increased potency of intra-accumbens nalmefene in ethanol-dependent rats. Neuropharmacology 61: 35-42.
43. Picker MJ, Mathewson C, Allen RM, (1996) Opioids and rate of positively reinforced behavior: III. Antagonism by the long-lasting kappa antagonist norbinaltorphimine. Behav Pharmacol 7: 495-504.
44. Portoghese PS, Lipkowski AW, Takemori AE, (1987) Binaltorphimine and nor-binaltorphimine, potent and selective kappa-opioid receptor antagonists. Life Sci 40: 1287-1292.
45. Redila VA, Chavkin C, (2008) Stress-induced reinstatement of cocaine seeking is mediated by the kappa opioid system. Psychopharmacology (Berl) 200: 59-70.
46. Samson HH, Doyle TF, (1985) Oral ethanol self-administration in the rat-effect of naloxone. Pharmacol Biochem Behav 22: 91-99.
47. Sauliere-Nzeh NA, Millot C, Corbani M, Mazeres S, Lopez A, Salome L, (2010) Agonist-selective dynamic compartmentalization of human mu opioid receptor as revealed by resolutive FRAP analysis. J Biol Chem 285: 14514-14520.
48. Schenk S, Partridge B, Shippenberg TS, (1999) U69593, a kappa-opioid agonist, decreases cocaine self-administration and decreases cocaine-produced drug-seeking. Psychopharmacology (Berl) 144: 339-346.
49. Shaham Y, Stewart J, (1995) Stress reinstates heroin-seeking in drug-free animals-an effect mimicking heroin, not withdrawal. Psychopharmacology (Berl) 119: 334-341.
50. Shalev U, Grimm JW, Shaham Y, (2002) Neurobiology of relapse to heroin and cocaine seeking: a review. Pharmacol Rev 54: 1-42.
51. Shippenberg TS, Zapata A, Chefer VI, (2007) Dynorphin and the pathophysiology of drug addiction. Pharmacol Ther 116: 306-321.
52. Spanagel R, Herz A, Shippenberg TS, (1992) Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc Natl Acad Sci U S A 89: 2046-2050.
53. Sperling RE, Gomes SM, Sypek EI, Carey AN, McLaughlin JP, (2010) Endogenous kappa-opioid mediation of stress-induced potentiation of ethanol-conditioned place preference and self-administration. Psychopharmacology (Berl) 210: 199-209.
54. Thomas JB, Atkinson RN, Rothman RB, Fix SE, Mascarella SW, Vinson NA, Xu H, Dersch CM, Lu Y, Cantrell BE, Zimmerman DM, Carroll FI, (2001) Identification of the first trans-(3R,4R)-dimethyl-4-(3-hydroxyphenyl)piperidine derivative to possess highly potent and selective opioid kappa receptor antagonist activity. J Med Chem 44: 2687-2690.
55. Thomas JB, Atkinson RN, Vinson NA, Catanzaro JL, Perretta CL, Fix SE, Mascarella SW, Rothman RB, Xu H, Dersch CM, Cantrell BE, Zimmerman DM, Carroll FI, (2003) Identification of (3R)-7-hydroxy-N-((1S)-1-[[(3R,4R)-4-(3- hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl]-2-methylpropyl)-1,2,3, 4-tetrahydro- 3-isoquinolinecarboxamide as a novel potent and selective opioid kappa receptor antagonist. J Med Chem 46: 3127-3137.
56. Walentiny DM, Vann RE, Warner JA, King LS, Seltzman HH, Navarro HA, Twine CE Jr, Thomas BF, Gilliam AF, Gilmour BP, Carroll FI, Wiley JL, (2010) Kappa opioid mediation of cannabinoid effects of the potent hallucinogen, salvinorin A, in rodents. Psychopharmacology (Berl) 210: 275-284.
57. Walker BM, Koob GF, (2008) Pharmacological evidence for a motivational role of kappa-opioid systems in ethanol dependence. Neuropsychopharmacology 33: 643-652.
58. Walker BM, Zorrilla EP, Koob GF, (2011) Systemic kappa-opioid receptor antagonism by nor-binaltorphimine reduces dependence-induced excessive alcohol self-administration in rats. Addict Biol 16: 116-119.
59. Williams KL, Woods JH, (1998) Oral ethanol-reinforced responding in rhesus monkeys: effects of opioid antagonists selective for the mu-, kappa-, or delta-receptor. Alcohol Clin Exp Res 22: 1634-1639.